Back |
home / stock / psti / psti message board
Subject | By | Source | When |
---|---|---|---|
They may at least get some revenue from | sekander | investorshub | 03/29/2023 1:22:34 AM |
Pretty much anyone whos last to market with | Scott999 | investorshub | 03/28/2023 8:18:18 PM |
PLURI IS IN THE SWEETSPOT !!! | FDApproved | investorshub | 03/28/2023 3:53:52 PM |
Tweet Tweet | FDApproved | investorshub | 03/28/2023 10:56:50 AM |
It's just Tutes trying to keep the turd afloat. | sekander | investorshub | 03/28/2023 2:50:00 AM |
Zzomeones been buying after hours at huge markups. | Scott999 | investorshub | 03/27/2023 4:42:15 PM |
As long as thats what he said that | Scott999 | investorshub | 03/25/2023 11:51:28 PM |
He added: An Ever After 1,400-liter bioreactor can | FDApproved | investorshub | 03/25/2023 8:06:59 PM |
Good Read !!! | FDApproved | investorshub | 03/25/2023 7:13:59 PM |
Next Tuesday | FDApproved | investorshub | 03/24/2023 7:35:19 PM |
Kaki takes a pay cut, and increases the | Scott999 | investorshub | 03/24/2023 12:57:07 PM |
Tweet Tweet | FDApproved | investorshub | 03/24/2023 12:30:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...